Welcome to our dedicated page for Flora Growth news (Ticker: FLGC), a resource for investors and traders seeking the latest updates and insights on Flora Growth stock.
Flora Growth Corp (FLGC) operates at the intersection of cannabis cultivation and pharmaceutical distribution, maintaining a vertically integrated model across 15+ countries. This page delivers essential updates about corporate milestones, regulatory compliance, and market expansion efforts.
Investors and industry observers will find comprehensive coverage of earnings reports, strategic partnerships, product launches, and operational developments. Our aggregation ensures you stay informed about FLGC’s commercial wholesale activities, consumer brand portfolio, and pharmaceutical-grade medical solutions.
Key updates include international supply chain advancements, CBD product innovations, and compliance achievements in regulated markets. Bookmark this page for real-time access to Flora Growth’s press releases and third-party analysis, curated to support informed decision-making.
Flora Growth Corp. (NASDAQ: FLGC) announced initial orders for its Mind Naturals and Awe CBD skincare brands targeting Spanish and Mexican markets, set for export in December 2021. The company aims to leverage innovative formulations and sustainable packaging. Mind Naturals was recognized as a top 12 finalist in Glosswire’s Global Pitch Competition, indicating strong industry recognition. Flora expects to expand its global reach, capitalizing on the growing European cannabis market projected to reach €3.2 billion by 2025. Additionally, VP Legal & Strategy, Damian Lopez, resigned effective November 30, 2021.
Flora Growth Corp. (NASDAQ: FLGC) has signed a licensing agreement with Tonino Lamborghini to produce and distribute luxury cannabis beverages, focusing on North America and Colombia. The product line will feature CBD and CBG and utilize Applied DNA Sciences' molecular tagging technology for product verification. The market for CBD products is expected to grow to $20 billion by 2024, with beverages being a key segment. The first product launch is scheduled for Q1 2022, which aligns with Flora's strategy to expand its brand portfolio.
Flora Growth Corp. (NASDAQ: FLGC) has formed a joint venture called FloVaria with Avaria Health & Beauty. This partnership aims to enhance the distribution of Avaria's KaLaya brand in Latin America, leveraging Flora's extensive Colombian distribution channels. Flora Lab will manufacture cannabinoid-infused products, focusing on CBD-enhanced formulations. KaLaya has achieved over a million units sold, primarily in Canada, and aims to expand into U.S. markets. Flora's recent $31.5 million capital raise will fund growth initiatives, including entry into the U.S. CBD market and expansion into Germany's cannabis market.
Flora Growth Corp. (NASDAQ:FLGC) has successfully closed an underwritten public offering of 11,500,000 units, each comprising one common share and one-half warrant, raising approximately
Flora Growth Corp. (NASDAQ: FLGC) announced a public offering of 10,000,000 units at $3.00 each, with each unit including a common share and a half warrant. The warrants can be exercised at $3.75 per share and will expire in five years. The offering is expected to close on November 23, 2021, subject to customary conditions. A.G.P./Alliance Global Partners is the sole book-running manager, with BMO Capital Markets and Roth Capital Partners as co-managers. Flora granted underwriters a 45-day option for an additional 15% of units for over-allotments. This offering aims to enhance operational capabilities.
Flora Growth Corp (NASDAQ: FLGC) has successfully acquired Vessel Brand Inc. for
Flora Growth Corp. (NASDAQ: FLGC) announced a definitive agreement to acquire Vessel Brand Inc. for US$30M, enhancing its premium brand portfolio. This acquisition aims to boost Flora's presence in the U.S. and Canadian cannabis markets by integrating Vessel's strong revenue growth and established go-to-market strategies. The leadership from Vessel will join Flora's management, promising to leverage their expertise for enhanced growth across Flora’s product offerings. The deal anticipates closing in mid-November, subject to customary conditions.
Flora Growth Corp. (NASDAQ: FLGC) has partnered with GlossWire to feature its skincare brands, MIND Naturals and Awe (Ô), on the GlossWire digital marketplace starting November 10, 2021. This collaboration is aimed at creating awareness and enhancing visibility for Flora's products ahead of the holiday season. GlossWire provides innovative technology that offers real-time data and insights for beauty brands. MIND Naturals recently gained recognition for its biodegradable packaging at the Cosmoprof North America event, highlighting the brand's innovative approach.
Flora Growth Corp. (NASDAQ: FLGC) announced a partnership with SHOWFIELDS to showcase its skincare brands, MIND Naturals and Awe (Ô), at the South Beach, Miami flagship location, beginning November 8, 2021. This collaboration aims to increase brand awareness among U.S. consumers ahead of the holiday season. The move follows the major recognition of MIND Naturals at Cosmoprof North America for its innovation in biodegradable packaging. Flora Growth leverages outdoor cultivation practices to supply cannabis derivatives across cosmetics, textiles, and food sectors.
Flora Growth Corp. (NASDAQ: FLGC) has received Good Agricultural and Collection Practices (GACP) certification, boosting its ability to export high-quality cannabis internationally. The company is harvesting non-psychoactive CBD cannabis, with yields exceeding expectations by 40-60%. Flora has also signed several Letters of Intent (LOIs) for dried flower sales in international markets including the EU and Australia, with fulfillment expected in Q4 2021. Their flagship facility, Cosechemos, has a production cost below $0.06 per gram, and an extraction facility is set to begin operations on November 15.